Avaliação de dois métodos para condicionamento e coleta de sêmen em quatro espécies do gênero Mazama

O desenvolvimento de técnicas não invasivas para a obtenção de sêmen de cervídeos facilita a criação de bancos genômicos, que são importantes instrumentos para a conservação ex situ e in situ. Este trabalho teve como objetivo criar uma metodologia não-invasiva de coleta de sêmen e comparar duas técnicas de coleta em quatro espécies do gênero Mazama: M. americana, M. gouazoubira, M. nana e M. nemorivaga. Para tanto, foram utilizados seis machos (M) e duas fêmeas (F) da espécie M. americana, 3M e 2F de M. gouazoubira, 1M e 1F de M. nana e 2M e 1F de M. nemorivaga. Para cada técnica testada, foi realizado um período de habituação dos animais ao manejo. Em seguida, duas técnicas de condicionamento e coleta foram avaliadas. Na primeira delas foi utilizada uma fêmea em estro com desvio lateral do pênis para vagina artificial (FEDL), obtendo-se a coleta de 50% dos indivíduos (100% dos machos de M. gouazoubira e 50% dos machos de M. americana), não obtendo ejaculados das demais espécies. Na segunda técnica, utilizando um manequim taxidermizado com urina de fêmea em estro (MUFE) não foi possível a coleta de nenhum ejaculado. Em todas as fases foi observado o comportamento do macho quanto ao tempo de interesse e aproximação, reflexo de "Flehmen", ato de cheirar ou lamber, exposição do pênis, ereção, número de falsas montas, tentativas de cópula e ocorrência de agressividade entre os animais

Seasonal prolactin secretion and its role in seasonal reproduction: A review

The majority of seasonally breeding mammals show a seasonal pattern of prolactin secretion with peak concentrations in spring or summer and a nadir in autumn or winter. Photoperiod influences prolactin secretion via its effects on the secretion of the pineal hormone melatonin. Preliminary evidence suggests that the effects of melatonin on both prolactin and gonadotrophin secretion are via a common target area, possibly within the anterior hypothalamus, and that differences in response to photoperiod may be due to differences in the processing and/or interpretation of the melatonin signal. In contrast to seasonal gonadotrophin secretion, the seasonal changes in prolactin are not due to changes in the sensitivity of a feedback loop and so must be due to direct effects on the hypothalamic pathways that control prolactin secretion. Little else can be said with confidence about the neuroendocrine mechanisms that lead to the seasonal changes in prolactin secretion. Dopamine and noradrenaline turnover in the arcuate nucleus and median eminence decrease under short daylength. If catecholamine turnover in these structures is positively correlated with catecholamine concentrations in the long or short hypophysial portal vessels, it is unlikely that the decrease in prolactin concentration in winter is due to the effects of increased concentrations of dopamine or noradrenaline in the portal vessels. There is, however, evidence for increased pituitary sensitivity to dopamine under short daylength, so increased dopamine concentrations may not be required for suppression of prolactin secretion at this time. In addition to the diminished secretion of prolactin under short daylength, rate of prolactin synthesis and pituitary content of prolactin also decline although the mechanisms that regulate these changes are poorly understood. Although all seasonal breeders show a seasonal change in prolactin secretion, there are continuously breeding species in which prolactin secretion is also under photoperiodic control. It is likely therefore that a seasonal pattern of prolactin secretion is only evidence of neuroendocrine sensitivity to changing photoperiod. Depending upon the species, this sensitivity to the seasonal changes in daylength may or may not be accompanied by seasonal changes in a biological endpoint such as seasonal reproduction or indeed other adaptations. Whether the seasonal change in prolactin secretion is an endocrine mediator of such adaptations remains in contention. Certainly in some species this signal does have a role in reproduction. For example, in species with an obligate seasonal embryonic diapause, the seasonal increase in prolactin can act as a luteotrophin (mink and western spotted skunk) or luteostatin (Bennett’s and tammar wallabies). In species where seasonal anoestrus or oligo- or azoospermia are due to a direct effect of photoperiod on gonadotrophin secretion, the seasonal changes in prolactin levels may also have been used by some species to influence seasonal reproduction. For example, the increase in prolactin in spring may be important in the golden hamster to augment increasing gonadotrophin concentrations and thus facilitate gonadal growth. The seasonal prolactin changes have also been causally linked with the seasonal pelage moult cycle and may also be involved in another seasonal adaptation, the annual cycle of growth and metabolism. In contrast, there are species such as the domesticated breeds of sheep, in which a role for the seasonal change in prolactin secretion is yet to be identified or may not exist

Localization and characterization of dopamine d1 receptors in sheep hypothalamus and striatum

Dopamine receptors are pharmacologically grouped as D-1 and D-2 receptors. Previous research in the ewe has shown that central D-1 receptors may have a role in facilitating prolactin release. The aims of this study were therefore to localize and characterize D-1 binding sites in the hypothalamus of sheep. For comparison, a known D-1 receptor-rich tissue (striatum) was also studied. The bioactivities of several D-1 analogues were also assessed for their efficacy in sheep tissue. In vitro autoradiography with [I-125]-SCH23982 was used to localize D-1 binding sites. The ventromedial hypothalamic nucleus (VMH) displayed moderate levels of specific binding, localized to the medial portion of the nucleus. Low levels of specific binding were seen in the preoptic area, supraoptic nucleus and anterior hypothalamic area. The suprachiasmatic nucleus, median eminence and arcuate nucleus did not show specific binding. As expected the striatum displayed high levels of specific binding. The VMH, preoptic area, median eminence, striatum and anterior pituitary were examined with radioligand binding studies to quantify and characterize D-1 binding sites. Scatchard analysis gave K-D 1.04 nM and B-max 127.4 fmol/mg protein for VMH and K-D 1.99 nM and B-max 454.6 fmol/mg protein for striatum. While specific binding occurred in the preoptic area and median eminence this binding did not show saturation characteristics. Specific binding was not observed in the anterior pituitary. Affinities determined by competitive binding studies showed that the binding sites in both VMH and striatum have the characteristics of a D-1 receptor, that is, high affinity for the D-1 agonists and antagonists, low affinity for dopamine and the serotonergic antagonist ketanserin and extremely low affinity for the D-2 agonists and noradrenaline. Adenylate cyclase studies showed that in the striatum dopamine and the D-1 agonists, fenoldopam and SKF38393, were able to cause significant dose-dependent increases in adenylate cyclase activity. In contrast the D-1 agonist, SKF82958, was inactive in this system. The D-1 antagonists SCH23390 and SCH39166, but not SKF83566, abolished the adenylate cyclase response to 50 mu M dopamine. In the VMH the D-1 agonist SKF38393, but not dopamine, stimulated adenylate cyclase activity. In conclusion, these results demonstrate that D-1 binding sites exist within the hypothalamus in the VMH and that these binding sites have the characteristics of D-1 receptors. These receptors are a potential site of action for dopamine in facilitating prolactin release. In addition, the results show that at least for some dopamine analogues, receptor binding affinity does not always correlate with biological activity

Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on prolactin, luteinizing hormone and growth hormone secretion in the ewe

This study was undertaken to investigate the roles of PACAP and VIP in the control of pituitary hormone secretion in the ewe. The first experiment was designed to identify any direct effects at the level of the pituitary and was conducted during the luteal phase of a prostaglandin-synchronized oestrous cycle. PACAP (0.008, 0.04, 0.2 and 1.0 nmol/min) or VIP (0.06, 0.2, 0.6 and 1.8 nmol/min) was infused into the carotid artery over a 10 min period. Blood samples were taken before and after the infusions so that plasma PRL, LH and GH concentrations could be measured. Blood pressure was also monitored to determine if the doses used were biologically active. In no case was an effect on hormone secretion observed. In contrast, the highest dose of each peptide induced an increase in heart rate to almost three-fold the resting value. Although both peptides are active in vivo, this result suggests that neither peptide has a direct effect on hormone release from the pituitary of prostaglandin-synchronized ewes. In a second experiment, we investigated whether the peptides had central effects on hormone secretion. Intracerebroventricular (ICV) injection of PACAP or VIP at the dose 10 nmol was tested in ovariectomized ewes. After injection, PACAP suppressed PRL and GH secretion so that plasma hormone concentrations from 1-3 h after injection were significantly different from the control (P < 0.05 for PRL, P < 0.01 for GH). In addition, PACAP significantly reduced mean LH concentration (P < 0.05) and LH pulse frequency (P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS

Dopamine D1 receptor analogues act centrally to stimulate prolactin secretion in ewes

It is well known that prolactin secretion is inhibited by dopamine activity via the pituitary dopamine D2 receptor. Dopamine D1 receptor analogues also affect prolactin levels although the mechanisms and physiological significance are poorly understood. The present study of the ewe was undertaken to characterize the effects of the D1 receptor agonist SKF 38393 and antagonist SCH 23390 on prolactin in this species and to determine whether the prolactin response to both drugs requires an intact hypothalamo-pituitary axis. Ovariectomized ewes were injected intravenously with vehicle, 0.2, 2 or 20 mg SKF 38393 (D1 agonist) or SCH 23390 (D1 antagonist). At the 20 mg dose, plasma prolactin concentrations were significantly (P < 0.01) increased by each drug and returned within an hour to control levels. When injected directly into the lateral ventricles of the brain (intracerebroventricular (i.c.v.) injection), a 100-fold lower dose of SKF 38393 (0.2 mg; P < 0.05) was sufficient to stimulate prolactin secretion. In contrast, i.c.v. injection of SCH 23390 (0.02 and 0.2 mg) had no effect on prolactin levels and at no dose was there evidence for suppression of prolactin levels. These results are in accord with earlier studies in the rat which suggested that the D1 agonist stimulated prolactin secretion via a direct effect on central dopamine D1 receptors whereas the D1 antagonist interacted with the pituitary dopamine D2 receptor to increase prolactin secretion. In a further experiment this hypothesis was tested in hypothalamo-pituitary disconnected ewes which were infused with dopamine (0.5 microgram/kg per min) for 3 h.(ABSTRACT TRUNCATED AT 250 WORDS

Effect of photoperiod on the annual cycle of testis growth in a tropical mammal, the little red flying fox, Pteropus scapulatus

Little red flying foxes (Pteropus scapulatus) are seasonal breeders: they mate in late spring/early summer, and young are born the following autumn. In captivity, males housed outdoors in a normal breeding colony in natural daylight showed a single cycle of testis growth and regression each year. During reproductive quiescence, testicular volume was approximately 2 cm; recrudescence began soon after the winter solstice; testicular volume was maximum at approximately 6.5 cm at the spring equinox; and regression was complete by the end of summer. To test whether photoperiod entrains or synchronizes the cycle, groups of males were housed indoors, without females, at constant temperature, and artificial lighting was timed to either mimic naturally changing daylength or provide alternating 3-month periods of short (11 h light:13 h dark) or long (16 h light:8 h dark) days (two groups, three months out of phase with each other). During 18 months, the applied photoperiod protocol had no effect on the frequency of testicular cycles (which remained at one per year), the time course of recrudescence and regression (as described above for normal outdoor control males), or the completeness of growth and regression stages. These results suggest that male P. scapulatus are not reproductively photoresponsive

Evidence for dopamine D1 receptor-mediated stimulation of prolactin secretion in ewes under long daylenght

International audienc

Effect of hypothalamic infusion of a dopamine D1 receptor antagonist on prolactin secretion in the ewe

International audienc

Evidence for dopamine D1 receptor-mediated stimulation of prolactin secretion in ewes under long daylenght

International audienc